临床路径在急性脑梗死超早期静脉溶栓中的应用  

The application of clinical pathway in the ultra-early stage of acute cerebral infarction with intravenous thrombolysis

作　　者：季云[1] 卢丽华[1] 茅裕伟[1] 姜新娣[1] 俞红[1] 

机构地区：[1]江苏省南通大学附属医院神经内科,南通226001

出　　处：《北方药学》2012年第3期51-51,6,共2页Journal of North Pharmacy

摘　　要：目的:观察实施临床路径对急性脑梗死患者超早期静脉溶栓的疗效。方法:将2007年7月～2010年12月静脉溶栓的急性脑梗死患者进行回顾性分析。非临床路径组20例,临床路径组22例。观察两组患者就诊至实施静脉溶栓所用时间、平均住院天数、住院费用、对护士的满意度评分。结果:临床路径组患者从就诊至开始静脉溶栓所需的时间、平均住院天数、住院费用明显降低,对护士的满意度评分高于非临床路径组,差异具有统计学意义(P<0.05)。结论:按临床路径进行护理可以为超早期脑梗死患者赢得溶栓机会,临床路径活动的程序化和标准化使护理由被动变为主动,便于患者获得最佳的护理服务。Objective：To research the effect of clinical pathway on patients with acute cerebral infarction who received intravenous thrombolysis at the ultra-early stage.Methods：We retrospectively analyzed patients of acute cerebral infarction who received intravenous thrombolysis therapy from July 2007 to December 2010. Non-clinical pathway group consists of 20 patients, clinical pathway group consists of 22 patients. We carefully noted and evaluated four parameters, including the time from door to treatment, the mean days of hospitalization, hospitalization costs and nurses＇ satisfaction score.Results：In our research, we found the four parameters of clinical pathway group were significantly different from that of non-clinical pathway group （P〈0.05）.Conclution：We conclude that patients of cerebral infarction at the ultra-early stage could get more chances of intravenous thrombolytic treatment if we nurse them with clinical pathway. The procedure and standardization of clinical pathway makes care from passive to active in order to ensure patients to acquire the best care services.

关 键 词：临床路径 脑梗死 静脉溶栓 

分 类 号：R743.33[医药卫生—神经病学与精神病学]